In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baxter International Inc.

https://www.baxter.com/

Latest From Baxter International Inc.

Immunogenicity Data Drove Monkeypox Dose-Sparring Decision…It Also Drove Initial Approval

Comfort with the initial approval based on inferred effectiveness may have made the current EUA process more palatable to US FDA officials but means there is a bigger gap in what’s known about the vaccine’s effectiveness overall.

Vaccines FDA

Prestige Consumer Opens Its FY2023 With Revenue Thirst Quenched By Hydralyte International Sales

Hydralyte line has 90% share in Australia’s hydration market and accounted for a large share of firm’s overall sales growth in its latest quarter as 28.9% international sales growth to $34.5m offset flat North American results at $242.4m.

Sales & Earnings Companies

Monkeypox Vaccine: US FDA Eyes Dose-Sparing Strategy For Jynneos

Switching method of administration from subcutaneous to intradermal would increase by five-fold the number of doses of Bavarian Nordic’s vaccine available to combat the outbreak; an EUA declaration would be needed to make this change, FDA commissioner Robert Califf said.

Vaccines Review Pathway

Cimerli Interchangeable Biosimilar Approved Without Switching Data

Citing low risk of a clinically impactful immunogenic response from systemic anti-drug antibodies and intraocular inflammation when alternating between Coherus’ Cimerli and Genentech’s reference product ranibizumab, US FDA says a switching study would not be informative.

Approvals Biosimilars
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Other Names / Subsidiaries
    • AesRX LLC
    • Althin Medical A.B.
    • Chatham Therapeutics
    • Cheetah Medical
    • Claris Injectables Limited
    • Fusion Medical Technologies, Inc.
    • Gambro AB
    • Immuno-US
    • Prism Pharmaceuticals, Inc.
    • Renal Therapy Services
    • SIGMA International Geneeral Medical Apparatus
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Wound Care Technologies, Inc.
    • Baxter Healthcare Corporation
UsernamePublicRestriction

Register